Assuntos
Doenças Autoimunes/diagnóstico , Biomarcadores Tumorais/sangue , Carcinoma Ductal Pancreático/diagnóstico , Imunoglobulina G/sangue , Mieloma Múltiplo/diagnóstico , Neoplasias Pancreáticas/diagnóstico , Pancreatite/diagnóstico , Idoso de 80 Anos ou mais , Doenças Autoimunes/sangue , Doenças Autoimunes/imunologia , Biomarcadores Tumorais/imunologia , Biópsia , Carcinoma Ductal Pancreático/sangue , Carcinoma Ductal Pancreático/imunologia , Carcinoma Ductal Pancreático/patologia , Diagnóstico Diferencial , Erros de Diagnóstico , Endossonografia , Feminino , Humanos , Imunoglobulina G/imunologia , Imuno-Histoquímica , Mieloma Múltiplo/sangue , Mieloma Múltiplo/imunologia , Mieloma Múltiplo/patologia , Neoplasias Pancreáticas/sangue , Neoplasias Pancreáticas/imunologia , Neoplasias Pancreáticas/patologia , Pancreatite/sangue , Pancreatite/imunologia , Valor Preditivo dos Testes , Tomografia Computadorizada por Raios X , Regulação para CimaAssuntos
Neoplasias dos Ductos Biliares/diagnóstico por imagem , Neoplasias dos Ductos Biliares/patologia , Carcinoma Neuroendócrino/diagnóstico por imagem , Carcinoma Neuroendócrino/patologia , Aspiração por Agulha Fina Guiada por Ultrassom Endoscópico , Regressão Neoplásica Espontânea , Adulto , Colangiopancreatografia Retrógrada Endoscópica , Feminino , Humanos , Tomografia Computadorizada por Raios XAssuntos
Fístula Anastomótica/terapia , Nefropatias Diabéticas/cirurgia , Drenagem/métodos , Endoscopia/métodos , Ductos Pancreáticos , Complicações Pós-Operatórias/terapia , Uretra , Fístula Anastomótica/diagnóstico por imagem , Cistostomia/métodos , Duodeno/cirurgia , Feminino , Humanos , Transplante de Rim/métodos , Pessoa de Meia-Idade , Pâncreas/cirurgia , Transplante de Pâncreas/métodos , Ductos Pancreáticos/diagnóstico por imagem , Complicações Pós-Operatórias/diagnóstico por imagemRESUMO
BACKGROUNDS: Maternal employment has been shown to be associated with childhood overweight and obesity (Ow/Ob), but the presence of family members who care for children in place of the mothers might influence children's Ow/Ob and lifestyles. The influence of maternal employment on children's Ow/Ob should be examined together with the presence of caregivers such as grandparents. OBJECTIVES: The effects of maternal employment and the presence of grandparents on lifestyles and Ow/Ob in Japanese pre-school children were investigated. DESIGN/SUBJECTS: Cross-sectional study on 2114 children aged 3-6 years who attended all childcare facilities in a city and primary caregivers was conducted. MEASUREMENTS: Children's weight and height, family environments (family members, maternal employment, single parent, number of siblings and parental Ow/Ob) and lifestyles (dietary, physical activity and sleeping habits) were surveyed using a self-administered questionnaire. Ow/Ob was defined by the International Obesity Task Force cut-offs. RESULTS: The eligible participants were 1765 children. The prevalence of Ow/Ob was 8.4% in boys and 9.9% in girls. Maternal employment was associated positively with irregular mealtimes, unfixed snacking times, bedtime after 10 p.m. and nighttime sleep duration of less than 10 h, whereas three-generation families were associated negatively with irregular mealtimes after adjustment for children's characteristics and family environments. Irregular mealtimes (OR (95% CI); 2.03 (1.36, 3.06)) and nighttime sleep duration of less than 10 h (1.96 (1.28, 3.01)) were associated with increased risks of being Ow/Ob. Both maternal employment and three-generation families were significantly associated with children's Ow/Ob. However, three-generation families maintained a significant association (1.59 (1.08, 2.35)) after adjustment for maternal employment. CONCLUSIONS: These study results suggest that the grandparents who care for pre-school children in place of mothers are more likely to contribute to childhood Ow/Ob than maternal employment. The family-focused lifestyle strategies to prevent childhood Ow/Ob must include grandparents who care for children.
Assuntos
Educação Infantil , Características da Família , Mães/estatística & dados numéricos , Obesidade/epidemiologia , Mulheres Trabalhadoras/estatística & dados numéricos , Criança , Comportamento Infantil , Educação Infantil/tendências , Pré-Escolar , Estudos Transversais , Dieta/tendências , Emprego , Feminino , Humanos , Japão/epidemiologia , Estilo de Vida , Masculino , Obesidade/etiologia , Sobrepeso/epidemiologia , Linhagem , Prevalência , Fatores SocioeconômicosRESUMO
BACKGROUND: The renin-angiotensin system (RAS) is thought to have a role in carcinogenesis, and RAS inhibition may prevent tumour growth. METHODS: We retrospectively investigated the impact of angiotensin I-converting enzyme inhibitors (ACEIs) and angiotensin II type-1 receptor blockers (ARBs) in 155 patients with pancreatic cancer receiving gemcitabine monotherapy. Patients were divided into three groups: the ACEI/ARB group (27 patients receiving an ACEI or ARB for hypertension (HT)), the non-ACEI/ARB with HT group (25 patients receiving antihypertensive drugs other than ACEIs or ARBs), and the non-HT group (103 patients receiving no antihypertensive drugs). RESULTS: Patient characteristics were not different, except for age and HT medications. Progression-free survival (PFS) was 8.7 months in the ACEI/ARB group, 4.5 months in the non-ACEI/ARB with HT group, and 3.6 months in the non-HT group. Overall survival (OS) was 15.1 months in the ACEI/ARB group, 8.9 months in the non-ACEI/ARB with HT group, and 9.5 months in the non-HT group. The use of ACEIs/ARBs was a significant prognostic factor for both PFS (P=0.032) and OS (P=0.014) in the multivariate analysis. CONCLUSIONS: The ACEIs/ARBs in combination with gemcitabine might improve clinical outcomes in patients with advanced pancreatic cancer. Prospective trials are needed to test this hypothesis.
Assuntos
Bloqueadores do Receptor Tipo 1 de Angiotensina II/administração & dosagem , Inibidores da Enzima Conversora de Angiotensina/administração & dosagem , Anti-Hipertensivos/administração & dosagem , Antimetabólitos Antineoplásicos/uso terapêutico , Desoxicitidina/análogos & derivados , Neoplasias Pancreáticas/tratamento farmacológico , Idoso , Idoso de 80 Anos ou mais , Desoxicitidina/administração & dosagem , Desoxicitidina/uso terapêutico , Quimioterapia Combinada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Pancreáticas/mortalidade , Prognóstico , Estudos Retrospectivos , GencitabinaAssuntos
Colangite/etiologia , Neoplasias Pancreáticas/complicações , Falha de Prótese/efeitos adversos , Stents/efeitos adversos , Colangite/cirurgia , Coledocostomia , Drenagem , Endoscopia Gastrointestinal , Feminino , Gastrostomia , Humanos , Pessoa de Meia-Idade , Ultrassonografia de IntervençãoAssuntos
Remoção de Dispositivo/métodos , Corpos Estranhos/cirurgia , Gastroscopia/métodos , Pâncreas/cirurgia , Stents , Doença Crônica , Falha de Equipamento , Feminino , Migração de Corpo Estranho/cirurgia , Gastroscopia/instrumentação , Humanos , Pessoa de Meia-Idade , Ductos Pancreáticos , Pancreatite Crônica/terapiaAssuntos
Neoplasias dos Ductos Biliares/patologia , Ductos Biliares Intra-Hepáticos/patologia , Biópsia por Agulha Fina/efeitos adversos , Colangiocarcinoma/patologia , Hemobilia/etiologia , Ultrassonografia de Intervenção/efeitos adversos , Idoso , Neoplasias dos Ductos Biliares/diagnóstico por imagem , Ductos Biliares Intra-Hepáticos/diagnóstico por imagem , Colangiocarcinoma/diagnóstico por imagem , Drenagem , Hemobilia/terapia , Humanos , MasculinoAssuntos
Adenocarcinoma/patologia , Neoplasias dos Ductos Biliares/patologia , Endoscopia do Sistema Digestório/instrumentação , Gastrectomia , Icterícia Obstrutiva/etiologia , Adenocarcinoma/complicações , Idoso de 80 Anos ou mais , Neoplasias dos Ductos Biliares/complicações , Endoscopia do Sistema Digestório/métodos , Humanos , Masculino , Neoplasias Gástricas/cirurgiaRESUMO
The epigenetic phenomenon could play a role in the interaction between chromatin and DNA-binding enzymes, allowing us to consider an association between the phenomenon and gene rearrangement. The correlation between methylation status and rearrangement of the T-cell receptor (TCR) beta chain gene in leukemia cells obtained from patients with acute myeloid leukemia (AML) was examined. All of the AML patients with a TCR-beta rearrangement had hypomethylated CCGG sequences within the J beta 1 region on the rearranged allele, while the germline allele had completely methylated CCmeGG sequence in this region, indicating a strong association between hypomethylation status and rearrangement of the TCR beta chain gene. In the DNA from AML patients with or without a TCR-beta rearrangement, the C beta 2 region contained completely methylated CCmeGG sequences, even though they express T-cell-associated antigens, including CD7; this pattern is quite different from that observed in T-cell neoplasias. Moreover, some AML patients showed a TCR-beta rearrangement without the presence of immunoglobulin heavy-chain gene rearrangement, suggesting that TCR beta chain gene involvement in AML is required for unknown factors other than common recombinase activity.
Assuntos
Alelos , DNA de Neoplasias/genética , Rearranjo Gênico da Cadeia beta dos Receptores de Antígenos dos Linfócitos T/genética , Leucemia Mieloide Aguda/genética , Adolescente , Adulto , Idoso , DNA de Neoplasias/química , Feminino , Granulócitos/química , Humanos , Cariotipagem , Masculino , Metilação , Pessoa de Meia-Idade , Mapeamento por RestriçãoRESUMO
We identified the telomere length at different hematological phases in 16 patients with myelodysplastic syndromes (MDS), showing disease evolution with a conventional Southern blot hybridization using the (TTAGGG)4 probe. The MDS patients studied were classified into three groups according to the pattern of telomere length reduction. The first group had telomere shortening at the time of disease diagnosis. In four of the six MDS patients in this group, the disease progressed within 6 months postdiagnosis and each of them survived for less than 1 year. Moreover, in this group four patients showed a 5q anomaly with or without additional changes, and 50% of patients in this group had complex chromosome abnormalities. The patients in the second group showed reductions in telomere length after disease progression; two of these three patients showed gradual disease progression and had one or two chromosome abnormalities. The third group comprised the remaining seven MDS patients; they showed no telomere reduction by disease evolution. Two patients in this group experienced rapid disease progression. These results may indicate that telomere reduction is linked to disease evolution in some MDS patients, perhaps as a result of genomic instability because patients with complex chromosome abnormalities were clustered in the first group. However, because some MDS patients show disease progression without telomere reduction, genetic changes, including point mutations of certain gene(s), may also contribute to disease progression. We further noted that telomere shortening at the time of MDS diagnosis might indicate a poor MDS prognosis.